These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 16424520)

  • 1. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.
    Kim MS; Choi CY; Kim JM; Chang HR; Woo HY
    Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of eye drops.
    Taşli H; Coşar G
    Cent Eur J Public Health; 2001 Aug; 9(3):162-4. PubMed ID: 11505742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
    Rosenthal RA; Buck SL; Henry CL; Schlech BA
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-use study of potential bacterial contamination of ophthalmic moxifloxacin.
    Mason BL; Alfonso EC; Miller D
    J Cataract Refract Surg; 2005 Sep; 31(9):1773-6. PubMed ID: 16246782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial contamination of multiple-use bottles of fluorescein ophthalmic solution.
    Kyei S; France D; Asiedu K
    Clin Exp Optom; 2019 Jan; 102(1):30-34. PubMed ID: 30058164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].
    Levrat F; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 1999 Mar; 22(2):186-91. PubMed ID: 10327349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial contamination of multi-use ophthalmic solutions in Kenya.
    Nentwich MM; Kollmann KH; Meshack J; Ilako DR; Schaller UC
    Br J Ophthalmol; 2007 Oct; 91(10):1265-8. PubMed ID: 17475714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The COMOD system. A preservative-free multidose container for eyedrops].
    Teping C; Wiedemann B
    Klin Monbl Augenheilkd; 1994 Oct; 205(4):210-7. PubMed ID: 7823521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial contamination of multiple-dose preservative-free hospital ophthalmic preparations in a tertiary care hospital.
    Chantra S; Hathaisaard P; Grzybowski A; Ruamviboonsuk P
    Adv Ophthalmol Pract Res; 2022; 2(1):100046. PubMed ID: 37846225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological study of cosmetic products during their use by consumers: health risk and efficacy of preservative systems.
    Campana R; Scesa C; Patrone V; Vittoria E; Baffone W
    Lett Appl Microbiol; 2006 Sep; 43(3):301-6. PubMed ID: 16910936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shelf life of antimicrobial ear drops.
    Clark MP; Pangilinan L; Wang A; Doyle P; Westerberg BD
    Laryngoscope; 2010 Mar; 120(3):565-9. PubMed ID: 20013841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic study of factors affecting eye drop size and dosing variability.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2005 Dec; 60(12):917-21. PubMed ID: 16398268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of preservative-free topical anesthetic drops in current use in ophthalmology departments.
    Pelosini L; Treffene S; Hollick EJ
    Cornea; 2009 Jan; 28(1):58-61. PubMed ID: 19092407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-mediated absorption of phenylmercuric nitrate on polyethylene and polypropylene containers in chloramphenicol eye drops.
    Charoo N; Chiew M; Tay A; Lian L
    Cutan Ocul Toxicol; 2014 Sep; 33(3):242-6. PubMed ID: 24147942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contamination rates between preserved and preservative-free fluoroquinolone eyedrops.
    Kim MS; Kim HK; Kim JM; Choi CY
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):817-24. PubMed ID: 23064697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.